Burcon NutraScience (TSE:BU – Get Free Report) (NYSE:BUR) issued its quarterly earnings results on Monday. The company reported C($0.32) EPS for the quarter, FiscalAI reports. Burcon NutraScience had a positive return on equity of 197.12% and a negative net margin of 387.14%. The business had revenue of C$1.04 million for the quarter.
Here are the key takeaways from Burcon NutraScience’s conference call:
- Burcon reported more than threefold year-over-year revenue growth, driven mainly by protein sales. Management expects significant sequential growth in Q3 as production volumes accelerate, though Q2 revenue fell 18% sequentially because of shipment timing and production constraints.
- The company reported more than 40 buying customers and 209 active projects, including 26 that have progressed beyond pallet orders. Management sees potential demand from GLP-1 users and food companies seeking high-purity proteins, but noted that customer projects can take 9–24 months to reach launch.
- Infrastructure problems at the manufacturing facility constrained production and shipments in Q2, and Burcon temporarily slowed onboarding new customers. Management said it has addressed the issues and plans to move from five-day to seven-day operations in the coming months.
- A board member provided an unsecured loan of up to CAD 4.2 million to support working capital and commercial operations while Burcon pursues a larger financing raise; management said the fundraising market remains challenging. The company is targeting positive cash flow in calendar 2027, a forward-looking goal dependent on scaling production and sales.
Burcon NutraScience Trading Down 13.8%
Shares of Burcon NutraScience stock opened at C$0.75 on Wednesday. Burcon NutraScience has a 1 year low of C$0.75 and a 1 year high of C$2.50. The firm has a market cap of C$9.52 million, a PE ratio of -0.65 and a beta of 2.80. The stock has a fifty day moving average price of C$1.21 and a 200-day moving average price of C$1.79. The company has a debt-to-equity ratio of -246.99, a current ratio of 0.18 and a quick ratio of 1.71.
Burcon NutraScience Company Profile
Burcon is a global technology leader in plant-based proteins for food and beverage applications. The Company has developed a portfolio of high-performance protein ingredients, including Peazzaz® pea proteins, FavaPro TM fava proteins and Puratein® canola proteins, and is focused on commercializing its technologies through manufacturing partnerships and growing customer adoption worldwide.
Read More
- Five stocks we like better than Burcon NutraScience
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.
